Phase III Randomized, Double-blind Study to Assess the Efficacy and Safety of alpha-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy.

Trial Profile

Phase III Randomized, Double-blind Study to Assess the Efficacy and Safety of alpha-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy.

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Apr 2012

At a glance

  • Drugs Thioctic acid (Primary)
  • Indications Diabetic neuropathies
  • Focus Therapeutic Use
  • Sponsors Bukwang Pharmaceutical
  • Most Recent Events

    • 24 Apr 2012 Actual end date Apr 2012 added as reported by ClinicalTrials.gov.
    • 24 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Dec 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top